Total Payments
$5,922
2022 Payments
$19.43
Companies
28
Transactions
332
Medicare Patients
788
Medicare Billing
$90,746
Payment Breakdown by Category
Food & Beverage$5,908 (99.8%)
Education$14.50 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,908 | 331 | 99.8% |
| Education | $14.50 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,403 | 77 | $0 (2022) |
| Gilead Sciences, Inc. | $732.73 | 46 | $0 (2021) |
| Janssen Biotech, Inc. | $666.56 | 36 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $442.19 | 27 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $425.31 | 28 | $0 (2021) |
| Daiichi Sankyo Inc. | $221.22 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $192.02 | 11 | $0 (2020) |
| Allergan, Inc. | $186.07 | 13 | $0 (2020) |
| Braintree Laboratories, Inc. | $176.92 | 9 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $159.62 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19.43 | 1 | ABBVIE INC. ($19.43) |
| 2021 | $880.70 | 48 | AbbVie Inc. ($398.93) |
| 2020 | $1,109 | 45 | Gilead Sciences, Inc. ($246.57) |
| 2019 | $1,477 | 101 | Gilead Sciences, Inc. ($321.73) |
| 2018 | $1,330 | 74 | AbbVie, Inc. ($305.85) |
| 2017 | $1,107 | 63 | AbbVie, Inc. ($252.92) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/28/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 06/30/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 06/30/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: VIROLOGY | ||||||
| 06/29/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/19/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 06/15/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Immunology | ||||||
| 06/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/11/2021 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/02/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/26/2021 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/26/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/20/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/12/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/07/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: VIROLOGY | ||||||
| 05/04/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Immunology | ||||||
| 04/27/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 7 | 252 | 293 | $120,110 | $25,178 |
| 2020 | 11 | 536 | 629 | $328,864 | $65,569 |
Total Patients
788
Total Services
922
Medicare Billing
$90,746
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 162 | $22,947 | $11,160 | 48.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 28 | 28 | $25,900 | $3,546 | 13.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 20 | 20 | $21,955 | $2,978 | 13.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 13 | 13 | $15,960 | $2,778 | 17.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 20 | 20 | $16,387 | $1,778 | 10.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $8,308 | $1,704 | 20.5% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $8,653 | $1,233 | 14.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 154 | 220 | $31,163 | $13,393 | 43.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 44 | 44 | $54,407 | $9,296 | 17.1% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 53 | 53 | $49,024 | $8,042 | 16.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 61 | 63 | $53,251 | $6,602 | 12.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 50 | 50 | $55,336 | $5,474 | 9.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 23 | 23 | $21,275 | $4,928 | 23.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 55 | 55 | $12,025 | $4,521 | 37.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 20 | $7,744 | $3,697 | 47.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 54 | $7,689 | $3,567 | 46.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 15 | 15 | $13,875 | $3,124 | 22.5% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 32 | 32 | $23,075 | $2,925 | 12.7% |
About Dr. Earl Darby, MD
Dr. Earl Darby, MD is a Gastroenterology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790743292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Earl Darby, MD has received a total of $5,922 in payments from pharmaceutical and medical device companies, with $19.43 received in 2022. These payments were reported across 332 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,908).
As a Medicare-enrolled provider, Darby has provided services to 788 Medicare beneficiaries, totaling 922 services with total Medicare billing of $90,746. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oakland, CA
- Active Since 05/03/2006
- Last Updated 11/11/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790743292
Products in Payments
- STELARA (Biological) $666.56
- HUMIRA (Biological) $366.48
- Creon (Drug) $287.34
- Entyvio (Biological) $242.40
- LINZESS (Drug) $241.33
- Humira (Biological) $234.36
- INJECTAFER (Drug) $221.22
- XIFAXAN (Drug) $209.13
- Mavyret (Drug) $186.54
- OCALIVA (Drug) $159.62
- ENTYVIO (Biological) $142.42
- CREON (Drug) $138.51
- MOVIPREP (Drug) $120.27
- Mulpleta (Drug) $116.33
- Cimzia (Drug) $115.35
- Vemlidy (Drug) $113.64
- Cook Medical Hemostasis (Device) $110.11
- SUPREP (Drug) $107.29
- INFLECTRA (Biological) $105.91
- VIBERZI (Drug) $93.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakland
Dr. Neil Stollman, Md, MD
Gastroenterology — Payments: $171,798
Gastroenterology $171,798
Ralph Peterson, Md, MD
Gastroenterology — Payments: $129,890
Gastroenterology $129,890
Ms. Susie Cohn, Md, MD
Gastroenterology — Payments: $13,313
Gastroenterology $13,313
Dr. Liana Vesga, Md, MD
Gastroenterology — Payments: $12,795
Gastroenterology $12,795
Dr. Silvia Villagomez, Md, MD
Gastroenterology — Payments: $11,402
Gastroenterology $11,402
Dr. Paul Chard, Md Phd, MD PHD
Gastroenterology — Payments: $4,744
Gastroenterology $4,744